Dr. Agarwal's Health Care Ltd
NSE:AGARWALEYE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr. Agarwal's Health Care Ltd
NSE:AGARWALEYE
|
IN |
|
Lavide Holding NV
AEX:LVIDE
|
NL |
|
ITC Ltd
NSE:ITC
|
IN |
|
A
|
Aurora Solar Technologies Inc
F:A82
|
CA |
|
S
|
Sandoz Group AG
SIX:SDZ
|
CH |
|
B
|
Beijing Jiaman Dress Co Ltd
SZSE:301276
|
CN |
|
C
|
Capital A Berhad
KLSE:CAPITALA
|
MY |
|
IIoT-Oxys Inc
OTC:ITOX
|
US |
|
E
|
Educational Book JSC in Ha Noi City
VN:EBS
|
VN |
|
Tryg A/S
CSE:TRYG
|
DK |
|
Beijing Shengtong Printing Co Ltd
SZSE:002599
|
CN |
|
Lagnam Spintex Ltd
NSE:LAGNAM
|
IN |
|
Moncler SpA
MIL:MONC
|
IT |
|
W
|
Wuxi Lead Intelligent Equipment Co Ltd
SZSE:300450
|
CN |
Wall Street
Price Targets
AGARWALEYE Price Targets Summary
Dr. Agarwal's Health Care Ltd
According to Wall Street analysts, the average 1-year price target for AGARWALEYE is 534.99 INR with a low forecast of 474.7 INR and a high forecast of 596.4 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AGARWALEYE's stock price target?
Price Target
534.99
INR
According to Wall Street analysts, the average 1-year price target for AGARWALEYE is 534.99 INR with a low forecast of 474.7 INR and a high forecast of 596.4 INR.
What is Dr. Agarwal's Health Care Ltd's Revenue forecast?
Projected CAGR
21%
For the last 1 year the compound annual growth rate for Dr. Agarwal's Health Care Ltd's revenue is 28%. The projected CAGR for the next 3 years is 21%.
What is Dr. Agarwal's Health Care Ltd's Operating Income forecast?
Projected CAGR
28%
For the last 1 year the compound annual growth rate for Dr. Agarwal's Health Care Ltd's operating income is 22%. The projected CAGR for the next 3 years is 28%.
What is Dr. Agarwal's Health Care Ltd's Net Income forecast?
Projected CAGR
46%
For the last 1 year the compound annual growth rate for Dr. Agarwal's Health Care Ltd's net income is 0%. The projected CAGR for the next 3 years is 46%.
